title: VA cooperative study on alcoholic hepatitis. II: Prognostic significance of protein-calorie malnutrition.
abstract: Three hundred and fifty-two patients with alcoholic hepatitis were evaluated for protein-calorie malnutrition (PCM). In order to facilitate data analysis of nutritional status, a PCM score was calculated for each patient using eight nutritional parameters. The PCM score correlated significantly with mortality, clinical severity of the liver disease, and biochemical liver dysfunction. When 30 day changes in the PCM scores were compared with 30 day caloric intake (expressed as percent basal energy expenditure (BEE], a marginally significant correlation was observed (p = 0.05). However, those patients who showed improvement in their PCM score over 30 days of hospitalization also improved their 6-mo and 1-yr survival. These data indicate that nutrition, as determined by the PCM score, has prognostic significance. Additional studies are needed to establish the beneficial role for vigorous protein-calorie nutritional therapy in the management of alcoholic hepatitis.
authors.forename: C L
authors.initials: CL
authors.lastname: Mendenhall
authors.forename: T
authors.initials: T
authors.lastname: Tosch
authors.forename: R E
authors.initials: RE
authors.lastname: Weesner
authors.forename: P
authors.initials: P
authors.lastname: Garcia-Pont
authors.forename: S J
authors.initials: SJ
authors.lastname: Goldberg
authors.forename: T
authors.initials: T
authors.lastname: Kiernan
authors.forename: L B
authors.initials: LB
authors.lastname: Seeff
authors.forename: M
authors.initials: M
authors.lastname: Sorell
authors.forename: C
authors.initials: C
authors.lastname: Tamburro
authors.forename: R
authors.initials: R
authors.lastname: Zetterman
mesh_terms: D002149:Energy Intake; D004734:Energy Metabolism; D006519:Hepatitis, Alcoholic / Q000150:complications* / Q000188:drug therapy / Q000473:pathology / Q000503:physiopathology; D006801:Humans; D008099:Liver / Q000473:pathology / Q000503:physiopathology; D010074:Oxandrolone / Q000627:therapeutic use; D011239:Prednisolone / Q000627:therapeutic use; D011379:Prognosis; D011502:Protein-Energy Malnutrition / Q000150:complications* / Q000401:mortality / Q000503:physiopathology
chemical_list: D010074:Oxandrolone; D011239:Prednisolone